journal cover

An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients

Metabolism: Clinical and Experimental

May 23, 2006

Noriko SatohYoshihiro Ogawa

Download from

Publisher
PubMed

Abstract

Postprandial hyperglycemia and hyperlipidemia are considered risk factors for cardiovascular disease. This study was designed to elucidate whether improving the postprandial state by voglibose, an alpha-glucosidase inhibitor, leads to the reduction of oxidative stress markers and solubl...read more

Mentioned in this Paper

Voglibose
Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Glucose Metabolism Disorders
Carbohydrate nutrients
Glycoside Hydrolase Inhibitors
Metformin
alpha-Glucosidase Inhibitor [EPC]
Meta-Analysis (Publications)
Adiponectin
Paper Details
References
  • References26
  • Citations14
123
  • References26
  • Citations14
12

Feeds With Similar Papers

Inflammation & Obesity

Obesity is the accumulation of abnormal or excessive fat that may interfere with the maintenance of an optimal state of health. The excess of macronutrients in the adipose tissues stimulates them to release inflammatory mediators such as tumor necrosis factor α and interleukin 6, and reduces production of adiponectin, predisposing to a pro-inflammatory state. Discover the latest research on inflammation and obesity here.

Cerebrovasculature & ApoE

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of neurodegenerative and cardiovascular diseases. This feed focuses on the role of this protein in cerebrovasculature and cerebrovascular dysfunction.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Metabolic Syndrome & Cardiovascular Disease

The constellation of dyslipidemia (hypertriglyceridemia and low levels of high-density lipoprotein cholesterol), elevated blood pressure, impaired glucose tolerance, and central obesity is now classified as metabolic syndrome, also called syndrome X. It is considered to be a precursor of cardiovascular disease. Discover the latest research on metabolic syndrome and cardiovascular disease here.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Metabolic Syndrome

Metabolic syndrome is characterized by obesity, insulin resistance, dyslipidemia and hypertension. It significantly increases the risk for cardiovascular and disease and type 2 diabetes. Increasing prevalence has been associated with the increasing rates of obesity worldwide. Here is the latest research on the metabolic syndrome.

Epidemiology of Cardiovascular Disease

A broad look at epidemiology of cardiovascular diseases, ranging from GWAS to population studies. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Nutrition & Aging

Nutrition improves health and well-being and is one of the important determining factors in successful aging. The mechanism by which nutrition plays a roll in aging is still being unveiled. Discover the latest research on nutrition and aging here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Metabolic Syndrome & T2DM

Metabolic syndrome is a complex disorder characterized by a cluster of metabolic abnormalities including hypertension, obesity, type 2 diabetes, and dyslipidemia. Here is the latest research on metabolic syndrome and type 2 diabetes mellitus.

Type 2 Diabetes

This feed focuses on Type 2 Diabetes, a disease where the body doesn’t produce or respond to insulin anymore, leading to abnormal glucose levels in the blood.

Peptides/Nanomedicine for AS

Using biocompatible and biodegradable peptides in nanomedicine for atherosclerosis provides targeting and therapeutic functionality that can assist in overcoming delivery barriers of traditional drugs and makes them attractive for in vivo use. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Obesity & CV Disease

Obesity is becoming a major health concern and epidemic worldwide. It is regarded as a systemic, low-grade inflammatory state and has been linked to several diseases, one of major importance is cardiovascular diseases. Here is the latest research on obesity and cardiovascular diseases.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's Disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's Disease here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Oxidative Stress & Diabetes

Oxidative stress plays a critical role in the development of many diseases including microvascular and cardiovascular complications in diabetes. Here is the latest research on the role of oxidative stress in diabetes.

Peripheral Nervous System Diseases

Peripheral nervous system diseases cover a wide spectrum of disease affecting the peripheral nerves, with the most common being diabetic neuropathy. Discover the latest research on peripheral nervous system diseases here.

Monogenetic Eating Disorders

Molecular genetic research of eating disorders is in its infancy. However, promising areas for future research have already been identified (e.g., 5-HT2A receptor gene, UCP-2/UCP-3 gene, estrogen receptor ß gene) and several large-scale linkage and association studies are currently underway. Discover the latest research on monogenetic eating disorders here.

Complications of Diabetes

This feed focuses on the complications of diabetes, including diabetic nephropathy, ketoacidosis, cardiomyopathy, and neuropathy.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

Proceedings of the National Academy of Sciences of the United States of AmericaNovember 22, 1994
H VlassaraM Steffes
© 2020 Meta ULC. All rights reserved

An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients

Metabolism: Clinical and Experimental

May 23, 2006

Noriko SatohYoshihiro Ogawa

PMID: 16713439

DOI: 10.1016/j.metabol.2006.01.016

Abstract

Postprandial hyperglycemia and hyperlipidemia are considered risk factors for cardiovascular disease. This study was designed to elucidate whether improving the postprandial state by voglibose, an alpha-glucosidase inhibitor, leads to the reduction of oxidative stress markers and solubl...read more

Mentioned in this Paper

Voglibose
Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Glucose Metabolism Disorders
Carbohydrate nutrients
Glycoside Hydrolase Inhibitors
Metformin
alpha-Glucosidase Inhibitor [EPC]
Meta-Analysis (Publications)
Adiponectin

Feeds With Similar Papers

Inflammation & Obesity

Obesity is the accumulation of abnormal or excessive fat that may interfere with the maintenance of an optimal state of health. The excess of macronutrients in the adipose tissues stimulates them to release inflammatory mediators such as tumor necrosis factor α and interleukin 6, and reduces production of adiponectin, predisposing to a pro-inflammatory state. Discover the latest research on inflammation and obesity here.

Cerebrovasculature & ApoE

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of neurodegenerative and cardiovascular diseases. This feed focuses on the role of this protein in cerebrovasculature and cerebrovascular dysfunction.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

Proceedings of the National Academy of Sciences of the United States of AmericaNovember 22, 1994
H VlassaraM Steffes
Paper Details
References
  • References26
  • Citations14
123
  • References26
  • Citations14
12

Download from

Publisher
PubMed
/papers/an-alpha-glucosidase-inhibitor-voglibose-reduces/16713439